Colon and Breast Cancer Diagnostics (COBRED)

COBRED aims at discovering colon cancer and breast cancer biomarkers for patient follow-up (monitoring markers) by exploiting the capacity of 3 state-of-the-art high-throughput technologies in an integrated systems biology approach. The goal is to identify biomarker candidates (metabolites, proteins, PBL derived mRNAs) capable to detect and assess the status of minimal residual disease, metastases and recurrence after surgery and chemotherapy. (See Goals).

COBRED is an EU FP6 funded 3-year Specific Targeted Research Project (STREP)

 
This work is supported by funding under the Sixth Research Framework Programme of the European Union, Project COBRED (LSHB-CT-2007-037730). This document has been created in the context of the COBRED project. All information is provided "as is" and no guarantee or warranty is given that the information is fit for any particular purpose. The user thereof uses the information at its sole risk and liability. The European Commission has no liability in respect of this document, which is merely representing the authors' view.